Variant report
Variant | rs62062273 |
---|---|
Chromosome Location | chr17:44092243-44092244 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs10445337 | 0.84[AMR][1000 genomes] |
rs10445338 | 0.84[AMR][1000 genomes] |
rs10445371 | 0.84[AMR][1000 genomes] |
rs10514897 | 0.88[AMR][1000 genomes] |
rs10514898 | 0.88[AMR][1000 genomes] |
rs1052551 | 0.84[AMR][1000 genomes] |
rs1052553 | 0.84[AMR][1000 genomes] |
rs1052587 | 0.88[AMR][1000 genomes] |
rs1052590 | 0.88[AMR][1000 genomes] |
rs1052594 | 0.88[AMR][1000 genomes] |
rs1076222 | 0.88[AMR][1000 genomes] |
rs1078268 | 0.84[AMR][1000 genomes] |
rs1078269 | 0.84[AMR][1000 genomes] |
rs1107820 | 0.88[AMR][1000 genomes] |
rs11079729 | 0.88[AMR][1000 genomes] |
rs1117253 | 0.84[AMR][1000 genomes] |
rs12149995 | 0.86[AMR][1000 genomes] |
rs12150064 | 0.88[AMR][1000 genomes] |
rs12150090 | 0.88[AMR][1000 genomes] |
rs12150127 | 0.84[AMR][1000 genomes] |
rs12150162 | 0.88[AMR][1000 genomes] |
rs12150170 | 0.88[AMR][1000 genomes] |
rs12150254 | 0.88[AMR][1000 genomes] |
rs12150336 | 0.88[AMR][1000 genomes] |
rs12150344 | 0.84[AMR][1000 genomes] |
rs12150438 | 0.88[AMR][1000 genomes] |
rs12150447 | 0.88[AMR][1000 genomes] |
rs12150469 | 0.89[AMR][1000 genomes] |
rs12150515 | 0.82[AMR][1000 genomes] |
rs12150542 | 0.88[AMR][1000 genomes] |
rs12150551 | 0.84[AMR][1000 genomes] |
rs12150558 | 0.84[AMR][1000 genomes] |
rs12150570 | 0.88[AMR][1000 genomes] |
rs12150611 | 0.84[AMR][1000 genomes] |
rs12150625 | 0.84[AMR][1000 genomes] |
rs12150627 | 0.84[AMR][1000 genomes] |
rs12150628 | 0.84[AMR][1000 genomes] |
rs12185225 | 0.88[AMR][1000 genomes] |
rs12185243 | 0.88[AMR][1000 genomes] |
rs1476554 | 0.84[AMR][1000 genomes] |
rs16940799 | 0.88[AMR][1000 genomes] |
rs17572147 | 0.81[AMR][1000 genomes] |
rs17572248 | 0.81[AMR][1000 genomes] |
rs17572361 | 0.81[AMR][1000 genomes] |
rs17572467 | 0.81[AMR][1000 genomes] |
rs17572495 | 0.81[AMR][1000 genomes] |
rs17572613 | 0.83[AMR][1000 genomes] |
rs17572627 | 0.83[AMR][1000 genomes] |
rs17573175 | 0.84[AMR][1000 genomes] |
rs17573245 | 0.84[AMR][1000 genomes] |
rs17573266 | 0.83[AMR][1000 genomes] |
rs17573447 | 0.84[AMR][1000 genomes] |
rs17573509 | 0.84[AMR][1000 genomes] |
rs17573593 | 0.84[AMR][1000 genomes] |
rs17573607 | 0.83[AMR][1000 genomes] |
rs17573858 | 0.88[AMR][1000 genomes] |
rs17573907 | 0.88[AMR][1000 genomes] |
rs17574040 | 0.88[AMR][1000 genomes] |
rs17574228 | 0.88[AMR][1000 genomes] |
rs17574361 | 0.88[AMR][1000 genomes] |
rs17574425 | 0.88[AMR][1000 genomes] |
rs17574604 | 0.88[AMR][1000 genomes] |
rs17574796 | 0.88[AMR][1000 genomes] |
rs17574824 | 0.88[AMR][1000 genomes] |
rs17575423 | 0.88[AMR][1000 genomes] |
rs17575437 | 0.88[AMR][1000 genomes] |
rs17575507 | 0.88[AMR][1000 genomes] |
rs17575556 | 0.88[AMR][1000 genomes] |
rs17575683 | 0.84[AMR][1000 genomes] |
rs17575773 | 0.84[AMR][1000 genomes] |
rs17575822 | 0.84[AMR][1000 genomes] |
rs17575850 | 0.84[AMR][1000 genomes] |
rs17576165 | 0.84[AMR][1000 genomes] |
rs17576200 | 0.84[AMR][1000 genomes] |
rs17576631 | 0.80[AMR][1000 genomes] |
rs17576695 | 0.81[AMR][1000 genomes] |
rs17576709 | 0.82[AMR][1000 genomes] |
rs17576779 | 0.81[AMR][1000 genomes] |
rs17650973 | 0.81[AMR][1000 genomes] |
rs17650991 | 0.81[AMR][1000 genomes] |
rs17651093 | 0.81[AMR][1000 genomes] |
rs17651134 | 0.81[AMR][1000 genomes] |
rs17651213 | 0.81[AMR][1000 genomes] |
rs17651243 | 0.81[AMR][1000 genomes] |
rs17651285 | 0.81[AMR][1000 genomes] |
rs17651483 | 0.84[AMR][1000 genomes] |
rs17651549 | 0.84[AMR][1000 genomes] |
rs17651700 | 0.84[AMR][1000 genomes] |
rs17651754 | 0.84[AMR][1000 genomes] |
rs17651857 | 0.84[AMR][1000 genomes] |
rs17651887 | 0.84[AMR][1000 genomes] |
rs17652066 | 0.84[AMR][1000 genomes] |
rs17652121 | 0.84[AMR][1000 genomes] |
rs17652337 | 0.84[AMR][1000 genomes] |
rs17652449 | 0.88[AMR][1000 genomes] |
rs17652502 | 0.88[AMR][1000 genomes] |
rs17652520 | 0.88[AMR][1000 genomes] |
rs17652748 | 0.88[AMR][1000 genomes] |
rs17652961 | 0.88[AMR][1000 genomes] |
rs17653162 | 0.88[AMR][1000 genomes] |
rs17653193 | 0.88[AMR][1000 genomes] |
rs17653211 | 0.88[AMR][1000 genomes] |
rs17653255 | 0.88[AMR][1000 genomes] |
rs17653836 | 0.88[AMR][1000 genomes] |
rs17653889 | 0.88[AMR][1000 genomes] |
rs17653906 | 0.86[AMR][1000 genomes] |
rs17653998 | 0.88[AMR][1000 genomes] |
rs17654016 | 0.88[AMR][1000 genomes] |
rs17659731 | 0.84[AMR][1000 genomes] |
rs17659743 | 0.84[AMR][1000 genomes] |
rs17659881 | 0.84[AMR][1000 genomes] |
rs17659953 | 0.84[AMR][1000 genomes] |
rs17660017 | 0.84[AMR][1000 genomes] |
rs17660065 | 0.84[AMR][1000 genomes] |
rs17660132 | 0.82[AMR][1000 genomes] |
rs17660167 | 0.84[AMR][1000 genomes] |
rs17660228 | 0.84[AMR][1000 genomes] |
rs17660251 | 0.84[AMR][1000 genomes] |
rs17660294 | 0.82[AMR][1000 genomes] |
rs17660337 | 0.84[AMR][1000 genomes] |
rs17660398 | 0.84[AMR][1000 genomes] |
rs17660464 | 0.81[AMR][1000 genomes] |
rs17660488 | 0.81[AMR][1000 genomes] |
rs1800547 | 0.81[AMR][1000 genomes] |
rs1981997 | 0.81[AMR][1000 genomes] |
rs1981998 | 0.81[AMR][1000 genomes] |
rs1991556 | 0.82[AMR][1000 genomes] |
rs2004673 | 0.84[AMR][1000 genomes] |
rs2004674 | 0.84[AMR][1000 genomes] |
rs2158257 | 0.88[AMR][1000 genomes] |
rs2217394 | 0.81[AMR][1000 genomes] |
rs2316948 | 0.88[AMR][1000 genomes] |
rs2316951 | 0.88[AMR][1000 genomes] |
rs2316952 | 0.88[AMR][1000 genomes] |
rs2316953 | 0.84[AMR][1000 genomes] |
rs2316954 | 0.84[AMR][1000 genomes] |
rs2316955 | 0.84[AMR][1000 genomes] |
rs2838 | 0.84[AMR][1000 genomes] |
rs34043286 | 0.88[AMR][1000 genomes] |
rs34579536 | 0.88[AMR][1000 genomes] |
rs35833914 | 0.88[AMR][1000 genomes] |
rs36076725 | 0.88[AMR][1000 genomes] |
rs3912060 | 0.84[AMR][1000 genomes] |
rs3912061 | 0.84[AMR][1000 genomes] |
rs3912062 | 0.80[AMR][1000 genomes] |
rs3912063 | 0.84[AMR][1000 genomes] |
rs41382552 | 0.88[AMR][1000 genomes] |
rs41437445 | 0.88[AMR][1000 genomes] |
rs4283261 | 0.88[AMR][1000 genomes] |
rs4306559 | 0.88[AMR][1000 genomes] |
rs4608377 | 0.88[AMR][1000 genomes] |
rs55649944 | 0.80[AMR][1000 genomes] |
rs55662347 | 0.84[AMR][1000 genomes] |
rs55690782 | 0.88[AMR][1000 genomes] |
rs55692232 | 0.84[AMR][1000 genomes] |
rs55714296 | 0.88[AMR][1000 genomes] |
rs55726761 | 0.88[AMR][1000 genomes] |
rs55736025 | 0.84[AMR][1000 genomes] |
rs55794067 | 0.81[AFR][1000 genomes] |
rs55825513 | 0.81[AMR][1000 genomes] |
rs55831516 | 0.84[AMR][1000 genomes] |
rs55864131 | 0.84[AMR][1000 genomes] |
rs55881134 | 0.88[AMR][1000 genomes] |
rs55893711 | 0.88[AMR][1000 genomes] |
rs55900347 | 0.81[AMR][1000 genomes] |
rs55913645 | 0.84[AMR][1000 genomes] |
rs55929190 | 0.84[AMR][1000 genomes] |
rs55947022 | 0.84[AMR][1000 genomes] |
rs55955207 | 0.80[AMR][1000 genomes] |
rs55972730 | 0.84[AMR][1000 genomes] |
rs55987700 | 0.84[AMR][1000 genomes] |
rs56041778 | 0.84[AMR][1000 genomes] |
rs56100031 | 0.84[AMR][1000 genomes] |
rs56166491 | 0.81[AMR][1000 genomes] |
rs56234850 | 0.84[AMR][1000 genomes] |
rs56240678 | 0.81[AMR][1000 genomes] |
rs56318865 | 0.84[AMR][1000 genomes] |
rs56323408 | 0.84[AMR][1000 genomes] |
rs62060760 | 0.86[AMR][1000 genomes] |
rs62060761 | 0.88[AMR][1000 genomes] |
rs62060762 | 0.86[AMR][1000 genomes] |
rs62060763 | 0.86[AMR][1000 genomes] |
rs62060764 | 0.88[AMR][1000 genomes] |
rs62060765 | 0.88[AMR][1000 genomes] |
rs62060767 | 0.88[AMR][1000 genomes] |
rs62060768 | 0.88[AMR][1000 genomes] |
rs62060769 | 0.88[AMR][1000 genomes] |
rs62060785 | 0.88[AMR][1000 genomes] |
rs62060786 | 0.88[AMR][1000 genomes] |
rs62060787 | 0.88[AMR][1000 genomes] |
rs62060792 | 0.84[AMR][1000 genomes] |
rs62060793 | 0.84[AMR][1000 genomes] |
rs62060794 | 0.84[AMR][1000 genomes] |
rs62060795 | 0.84[AMR][1000 genomes] |
rs62060796 | 0.84[AMR][1000 genomes] |
rs62060797 | 0.84[AMR][1000 genomes] |
rs62060798 | 0.84[AMR][1000 genomes] |
rs62060799 | 0.84[AMR][1000 genomes] |
rs62060800 | 0.84[AMR][1000 genomes] |
rs62060801 | 0.84[AMR][1000 genomes] |
rs62060802 | 0.84[AMR][1000 genomes] |
rs62060809 | 0.83[AMR][1000 genomes] |
rs62060810 | 0.84[AMR][1000 genomes] |
rs62060812 | 0.84[AMR][1000 genomes] |
rs62060834 | 0.84[AMR][1000 genomes] |
rs62060835 | 0.84[AMR][1000 genomes] |
rs62060836 | 0.84[AMR][1000 genomes] |
rs62060838 | 0.84[AMR][1000 genomes] |
rs62060839 | 0.84[AMR][1000 genomes] |
rs62060840 | 0.84[AMR][1000 genomes] |
rs62060841 | 0.84[AMR][1000 genomes] |
rs62060842 | 0.80[AMR][1000 genomes] |
rs62060844 | 0.83[AMR][1000 genomes] |
rs62060845 | 0.84[AMR][1000 genomes] |
rs62060846 | 0.84[AMR][1000 genomes] |
rs62060847 | 0.84[AMR][1000 genomes] |
rs62060850 | 0.84[AMR][1000 genomes] |
rs62060851 | 0.84[AMR][1000 genomes] |
rs62060852 | 0.84[AMR][1000 genomes] |
rs62060853 | 0.84[AMR][1000 genomes] |
rs62060855 | 0.84[AMR][1000 genomes] |
rs62060856 | 0.84[AMR][1000 genomes] |
rs62060858 | 0.84[AMR][1000 genomes] |
rs62060859 | 0.84[AMR][1000 genomes] |
rs62061764 | 0.84[AMR][1000 genomes] |
rs62061766 | 0.82[AMR][1000 genomes] |
rs62061767 | 0.82[AMR][1000 genomes] |
rs62061771 | 0.84[AMR][1000 genomes] |
rs62061772 | 0.84[AMR][1000 genomes] |
rs62061788 | 0.84[AMR][1000 genomes] |
rs62061789 | 0.84[AMR][1000 genomes] |
rs62061790 | 0.84[AMR][1000 genomes] |
rs62061791 | 0.82[AMR][1000 genomes] |
rs62061793 | 0.84[AMR][1000 genomes] |
rs62061795 | 0.82[AMR][1000 genomes] |
rs62061796 | 0.81[AMR][1000 genomes] |
rs62061798 | 0.81[AMR][1000 genomes] |
rs62061802 | 0.81[AMR][1000 genomes] |
rs62061803 | 0.81[AMR][1000 genomes] |
rs62061807 | 0.82[AMR][1000 genomes] |
rs62061808 | 0.81[AMR][1000 genomes] |
rs62062133 | 0.86[AMR][1000 genomes] |
rs62062134 | 0.88[AMR][1000 genomes] |
rs62062136 | 0.88[AMR][1000 genomes] |
rs62062137 | 0.88[AMR][1000 genomes] |
rs62062265 | 0.88[AMR][1000 genomes] |
rs62062266 | 0.88[AMR][1000 genomes] |
rs62062267 | 0.88[AMR][1000 genomes] |
rs62062268 | 0.88[AMR][1000 genomes] |
rs62062269 | 0.88[AMR][1000 genomes] |
rs62062270 | 0.88[AMR][1000 genomes] |
rs62062272 | 0.89[AMR][1000 genomes] |
rs62062274 | 0.88[AMR][1000 genomes] |
rs62062275 | 0.88[AMR][1000 genomes] |
rs62062276 | 0.88[AMR][1000 genomes] |
rs62062277 | 0.88[AMR][1000 genomes] |
rs62062278 | 0.84[AMR][1000 genomes] |
rs62062279 | 0.85[AMR][1000 genomes] |
rs62062280 | 0.84[AMR][1000 genomes] |
rs62062281 | 0.88[AMR][1000 genomes] |
rs62062282 | 0.88[AMR][1000 genomes] |
rs62062283 | 0.88[AMR][1000 genomes] |
rs62062284 | 0.88[AMR][1000 genomes] |
rs62062285 | 0.88[AMR][1000 genomes] |
rs62062286 | 0.86[AMR][1000 genomes] |
rs62062289 | 0.88[AMR][1000 genomes] |
rs62062290 | 0.88[AMR][1000 genomes] |
rs62062292 | 0.88[AMR][1000 genomes] |
rs62062293 | 0.88[AMR][1000 genomes] |
rs62062294 | 0.86[AMR][1000 genomes] |
rs62062295 | 0.88[AMR][1000 genomes] |
rs62062296 | 0.84[AMR][1000 genomes] |
rs62062297 | 0.88[AMR][1000 genomes] |
rs62062321 | 0.88[AMR][1000 genomes] |
rs62062322 | 0.88[AMR][1000 genomes] |
rs62062323 | 0.89[AMR][1000 genomes] |
rs62062324 | 0.86[AMR][1000 genomes] |
rs62062325 | 0.86[AMR][1000 genomes] |
rs62063291 | 0.81[AMR][1000 genomes] |
rs62063292 | 0.81[AMR][1000 genomes] |
rs62063293 | 0.81[AMR][1000 genomes] |
rs62063294 | 0.81[AMR][1000 genomes] |
rs62063295 | 0.81[AMR][1000 genomes] |
rs62063296 | 0.81[AMR][1000 genomes] |
rs62063297 | 0.81[AMR][1000 genomes] |
rs62063298 | 0.81[AMR][1000 genomes] |
rs62063299 | 0.81[AMR][1000 genomes] |
rs62063300 | 0.81[AMR][1000 genomes] |
rs62063303 | 0.81[AMR][1000 genomes] |
rs62063304 | 0.81[AMR][1000 genomes] |
rs62063305 | 0.81[AMR][1000 genomes] |
rs62063306 | 0.81[AMR][1000 genomes] |
rs62063670 | 0.88[AMR][1000 genomes] |
rs62063671 | 0.88[AMR][1000 genomes] |
rs62063672 | 0.88[AMR][1000 genomes] |
rs62063673 | 0.88[AMR][1000 genomes] |
rs62063675 | 0.88[AMR][1000 genomes] |
rs62063676 | 0.83[AMR][1000 genomes] |
rs62063677 | 0.88[AMR][1000 genomes] |
rs62063678 | 0.88[AMR][1000 genomes] |
rs62063680 | 0.88[AMR][1000 genomes] |
rs62063681 | 0.81[AMR][1000 genomes] |
rs62063682 | 0.88[AMR][1000 genomes] |
rs62063683 | 0.88[AMR][1000 genomes] |
rs62063684 | 0.88[AMR][1000 genomes] |
rs62063686 | 0.86[AMR][1000 genomes] |
rs62063774 | 0.81[AMR][1000 genomes] |
rs62063775 | 0.81[AMR][1000 genomes] |
rs62063776 | 0.81[AMR][1000 genomes] |
rs62063777 | 0.81[AMR][1000 genomes] |
rs62063778 | 0.81[AMR][1000 genomes] |
rs62063779 | 0.81[AMR][1000 genomes] |
rs62063781 | 0.81[AMR][1000 genomes] |
rs62063783 | 0.84[AMR][1000 genomes] |
rs62063784 | 0.84[AMR][1000 genomes] |
rs62063786 | 0.84[AMR][1000 genomes] |
rs62063787 | 0.84[AMR][1000 genomes] |
rs62063794 | 0.84[AMR][1000 genomes] |
rs62063795 | 0.84[AMR][1000 genomes] |
rs62063796 | 0.84[AMR][1000 genomes] |
rs62063797 | 0.84[AMR][1000 genomes] |
rs62063798 | 0.84[AMR][1000 genomes] |
rs62063800 | 0.80[AMR][1000 genomes] |
rs62063842 | 0.84[AMR][1000 genomes] |
rs62063845 | 0.84[AMR][1000 genomes] |
rs62063846 | 0.84[AMR][1000 genomes] |
rs62063849 | 0.84[AMR][1000 genomes] |
rs62063850 | 0.84[AMR][1000 genomes] |
rs62063851 | 0.84[AMR][1000 genomes] |
rs62063852 | 0.84[AMR][1000 genomes] |
rs62063853 | 0.84[AMR][1000 genomes] |
rs62063854 | 0.84[AMR][1000 genomes] |
rs62063855 | 0.84[AMR][1000 genomes] |
rs62063856 | 0.83[AMR][1000 genomes] |
rs62063857 | 0.84[AMR][1000 genomes] |
rs62063859 | 0.84[AMR][1000 genomes] |
rs62064660 | 0.83[AMR][1000 genomes] |
rs62064661 | 0.84[AMR][1000 genomes] |
rs62064662 | 0.84[AMR][1000 genomes] |
rs62064663 | 0.84[AMR][1000 genomes] |
rs62064665 | 0.84[AMR][1000 genomes] |
rs62064666 | 0.82[AMR][1000 genomes] |
rs62064667 | 0.82[AMR][1000 genomes] |
rs62064668 | 0.84[AMR][1000 genomes] |
rs62064669 | 0.88[AMR][1000 genomes] |
rs62064670 | 0.88[AMR][1000 genomes] |
rs62064671 | 0.88[AMR][1000 genomes] |
rs62064672 | 0.88[AMR][1000 genomes] |
rs62064674 | 0.88[AMR][1000 genomes] |
rs62064675 | 0.88[AMR][1000 genomes] |
rs62641967 | 0.81[AMR][1000 genomes] |
rs63750417 | 0.84[AMR][1000 genomes] |
rs733966 | 0.88[AMR][1000 genomes] |
rs733967 | 0.88[AMR][1000 genomes] |
rs733968 | 0.88[AMR][1000 genomes] |
rs733969 | 0.86[AMR][1000 genomes] |
rs7350928 | 0.88[AMR][1000 genomes] |
rs747152 | 0.88[AMR][1000 genomes] |
rs754512 | 0.81[AMR][1000 genomes] |
rs754513 | 0.81[AMR][1000 genomes] |
rs7687 | 0.88[AMR][1000 genomes] |
rs8712 | 0.84[AMR][1000 genomes] |
rs876944 | 0.88[AMR][1000 genomes] |
rs919461 | 0.84[AMR][1000 genomes] |
rs919462 | 0.84[AMR][1000 genomes] |
rs919464 | 0.84[AMR][1000 genomes] |
rs9468 | 0.88[AMR][1000 genomes] |
rs9709338 | 0.88[AMR][1000 genomes] |
rs974291 | 0.84[AMR][1000 genomes] |
rs974292 | 0.84[AMR][1000 genomes] |
rs974293 | 0.84[AMR][1000 genomes] |
rs974294 | 0.84[AMR][1000 genomes] |
rs974295 | 0.84[AMR][1000 genomes] |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1065930 | chr17:43467291-44151468 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 51 gene(s) | inside rSNPs | diseases |
2 | nsv869210 | chr17:43593476-44224221 | Strong transcription Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
3 | nsv948932 | chr17:43651040-44176717 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
4 | nsv817315 | chr17:43651731-44351152 | Enhancers ZNF genes & repeats Bivalent Enhancer Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
5 | nsv529777 | chr17:43653227-44351644 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
6 | nsv529535 | chr17:43655747-44176717 | Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
7 | nsv492045 | chr17:43655747-44176717 | Weak transcription Strong transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
8 | nsv534661 | chr17:43655747-44224221 | Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
9 | nsv1067695 | chr17:43655747-44351152 | Weak transcription Active TSS Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
10 | nsv529378 | chr17:43655747-44351152 | Enhancers Active TSS Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
11 | nsv916831 | chr17:43656693-44176717 | Strong transcription Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
12 | nsv529778 | chr17:43675408-44351152 | Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
13 | nsv529779 | chr17:43693607-44176717 | Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
14 | nsv1057146 | chr17:43706685-44160002 | Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
15 | nsv543347 | chr17:43706685-44160002 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
16 | nsv1067556 | chr17:43706685-44176717 | Weak transcription Bivalent/Poised TSS Strong transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
17 | nsv543348 | chr17:43706685-44176717 | Weak transcription Enhancers Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
18 | nsv1065215 | chr17:43706685-44224221 | Enhancers Flanking Bivalent TSS/Enh Strong transcription Weak transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
19 | nsv543349 | chr17:43706685-44224221 | Active TSS Genic enhancers Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
20 | nsv529780 | chr17:43706686-44485971 | Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
21 | nsv1056301 | chr17:43706885-44176717 | Active TSS Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
22 | nsv543350 | chr17:43706885-44176717 | Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
23 | nsv1067377 | chr17:43706885-44224221 | Weak transcription Active TSS Strong transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
24 | nsv543351 | chr17:43706885-44224221 | Genic enhancers Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
25 | nsv529781 | chr17:43706886-44129244 | ZNF genes & repeats Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
26 | nsv529524 | chr17:43706886-44138572 | Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
27 | nsv817538 | chr17:43706886-44156558 | Active TSS Weak transcription Enhancers Genic enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
28 | nsv869192 | chr17:43706886-44171947 | Flanking Bivalent TSS/Enh Weak transcription Strong transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
29 | nsv529792 | chr17:43706886-44176171 | Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
30 | nsv1067696 | chr17:43706886-44176717 | Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
31 | nsv529730 | chr17:43706886-44176717 | Enhancers Strong transcription Weak transcription Genic enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
32 | nsv817460 | chr17:43706886-44351152 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
33 | nsv529278 | chr17:43706886-44694283 | Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
34 | nsv1067136 | chr17:43713566-44151468 | Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
35 | nsv543352 | chr17:43713566-44151468 | Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
36 | nsv1057514 | chr17:43713566-44176717 | Weak transcription Bivalent/Poised TSS Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
37 | nsv543353 | chr17:43713566-44176717 | Weak transcription Active TSS Bivalent/Poised TSS Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
38 | nsv1061394 | chr17:43713566-44224221 | Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
39 | nsv543354 | chr17:43713566-44224221 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Genic enhancers Bivalent/Poised TSS Strong transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
40 | nsv529793 | chr17:43715080-44176717 | Strong transcription Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
41 | nsv534157 | chr17:43717703-44345038 | Enhancers Strong transcription Active TSS Bivalent Enhancer Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
42 | nsv529794 | chr17:43717703-44351152 | Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Enhancers Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
43 | nsv949334 | chr17:43741452-44118999 | Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
44 | nsv948678 | chr17:43741452-44162597 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
45 | nsv949395 | chr17:43741452-44176717 | Weak transcription Strong transcription Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
46 | nsv948604 | chr17:43741452-44364056 | Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
47 | nsv529795 | chr17:43751674-44351152 | Flanking Active TSS Strong transcription Enhancers Weak transcription Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
48 | nsv949112 | chr17:43763241-44364056 | Weak transcription Transcr. at gene 5' and 3' Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
49 | nsv1061337 | chr17:43816854-44176717 | Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
50 | nsv543356 | chr17:43816854-44176717 | Weak transcription Strong transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:44052000-44102600 | Weak transcription | Right Ventricle | heart |
2 | chr17:44081800-44104800 | Weak transcription | Right Atrium | heart |
3 | chr17:44083400-44095600 | Weak transcription | Pancreas | Pancrea |
4 | chr17:44085600-44104600 | Weak transcription | Fetal Brain Male | brain |
5 | chr17:44087600-44097600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr17:44087800-44103800 | Weak transcription | NH-A | brain |
7 | chr17:44088600-44099200 | Weak transcription | A549 | lung |
8 | chr17:44090200-44092600 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr17:44090600-44098400 | Weak transcription | Stomach Smooth Muscle | stomach |
10 | chr17:44090800-44093200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr17:44091200-44095200 | Weak transcription | Lung | lung |
12 | chr17:44091200-44098600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
13 | chr17:44091400-44097600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
14 | chr17:44091600-44098200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr17:44091600-44100200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr17:44091800-44092400 | Enhancers | HepG2 | liver |
17 | chr17:44091800-44094400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr17:44091800-44095600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
19 | chr17:44091800-44095600 | Weak transcription | Fetal Brain Female | brain |
20 | chr17:44091800-44095600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
21 | chr17:44091800-44095800 | Weak transcription | Brain Angular Gyrus | brain |
22 | chr17:44091800-44095800 | Weak transcription | Brain Germinal Matrix | brain |
23 | chr17:44091800-44097600 | Weak transcription | Adipose Nuclei | Adipose |
24 | chr17:44091800-44098800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
25 | chr17:44091800-44099600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
26 | chr17:44091800-44099800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
27 | chr17:44091800-44100000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
28 | chr17:44091800-44100000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
29 | chr17:44091800-44102200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
30 | chr17:44091800-44102200 | Weak transcription | Placenta Amnion | Placenta Amnion |
31 | chr17:44091800-44103200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
32 | chr17:44092000-44093200 | Weak transcription | Brain Hippocampus Middle | brain |
33 | chr17:44092000-44094000 | Weak transcription | HSMM | muscle |
34 | chr17:44092000-44094200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
35 | chr17:44092000-44094200 | Weak transcription | HSMMtube | muscle |
36 | chr17:44092000-44095600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
37 | chr17:44092000-44095600 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
38 | chr17:44092000-44095600 | Weak transcription | Brain Substantia Nigra | brain |
39 | chr17:44092000-44095800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
40 | chr17:44092000-44095800 | Weak transcription | Brain Anterior Caudate | brain |
41 | chr17:44092000-44095800 | Weak transcription | Brain Cingulate Gyrus | brain |
42 | chr17:44092000-44095800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
43 | chr17:44092000-44095800 | Weak transcription | Fetal Stomach | stomach |
44 | chr17:44092000-44095800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
45 | chr17:44092000-44097600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
46 | chr17:44092000-44098600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
47 | chr17:44092000-44099600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
48 | chr17:44092000-44100000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
49 | chr17:44092000-44102000 | Weak transcription | NHLF | lung |
50 | chr17:44092000-44102200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |